Results 261 to 270 of about 5,214,305 (354)

Knowledge and use of complementary therapies in a tertiary care hospital in France: A preliminary study. [PDF]

Medicine (Baltimore), 2020
Michel-Cherqui M, Had-Bujon R, Mongereau A, Delannoy C, Feliot E, Scotté F, Fischler M.   +6 more
europepmc   +1 more source

Probiotics Are Food; Herbs Are Plants; What’s the Risk? Informed Consent for Complementary and Integrative Therapies [PDF]

, 2010
Hanson, Lisa, VandeVusse, Leona
core   +2 more sources

Complementary and alternative therapies for obesity

, 2002
Dey Lucy Yuan Chun-Su
openalex   +2 more sources

The Award winning ?Completing the circle? complementary therapy service initiative at Christie NHS Hospital Manchester [PDF]

, 2004
P MACKERETH
openalex   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source

Integrative Oncology for High-Grade Glioma: A Case Report on the Combined Effects of Oncothermia and Complementary Therapies. [PDF]

Cureus
Nair PM, Ramalakshmi R, Devibala M, Saranya M, Sivaranjini S, Thangavelu R, Mahalingam M.   +6 more
europepmc   +1 more source

Complementary and integrative medical therapies, the FDA, and the NIH: definitions and regulation

, 2003
M. Cohen
openalex   +1 more source

Use of Complementary and Alternative Medical Therapies in a Pediatric Neurology Clinic [PDF]

, 2005
Isaac Soo, Jean K. Mah, Karen Barlow, Lorie Hamiwka, Elaine Wirrell   +4 more
openalex   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Use of complementary therapies and supportive measures of patients with intracranial gliomas-a prospective evaluation in an outpatient clinic. [PDF]

J Neurooncol
Ottenhausen M, Renovanz M, Bartz I, Poplawski A, Kalasauskas D, Krenzlin H, Keric N, Ringel F.   +7 more
europepmc   +1 more source